Anemia
From the Journals
Matched transplant improves stroke risk indicator in sickle cell anemia
Matched sibling donor hematopoietic stem cell transplants reduced an indicator of stroke risk, suggesting that the intervention may improve...
Clinical Review
Aplastic Anemia: Evaluation and Diagnosis
From the Journals
Plerixafor produced dramatic responses in severe WHIM syndrome
The treatment was effective and well tolerated in patients who could not receive granulocyte colony-stimulating factor therapy.
News
Sickle cell infusion gains FDA breakthrough designation
The investigational therapy is aimed at preventing vasoocclusive crises.
News
Chemo for solid tumors and risk of tMDS/AML
Chemotherapy for solid tumors is associated with an increased risk of therapy-related myelodysplastic syndromes or acute myeloid leukemia (tMDS/...
News
Potential treatment on the horizon for cold agglutinin disease
In a first-in-human trial, sutimlimab rapidly halted hemolysis, corrected anemia, precluded the need for transfusion, and caused no serious...
News
Team reports long-term effects of blood management
An initiative that reduced red blood cell (RBC) transfusions and increased moderate anemia in hospital did not adversely impact patients long-term...
News
FDA approves ravulizumab for PNH
The U.S.
News
FDA approves ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria
The drug’s novel formulation means that patients can be treated every eight weeks, instead of every two weeks as is the case with the previously...
News
CHMP backs lusutrombopag for severe thrombocytopenia
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for lusutrombopag to treat severe...
News
FDA aims to boost safety of platelets for transfusion
The agency is seeking input on ways to decrease the risk of bacterial contamination in platelets stored for 5 and 7 days after collection.